Teladoc’s (NYSE:TDOC) Q4 Earnings Results: Revenue In Line With Expectations But Stock Drops 11.7%
Digital medical services platform Teladoc Health (NYSE:TDOC) met Wall Street’s revenue expectations in Q4 CY2024, but sales fell by 3% year on year to $640.5 million. On the other hand, next quarter’s revenue guidance of $618.5 million was less impressive, coming in 2.4% below analysts’ estimates. Its GAAP loss of $0.28 per share was 26.1% below analysts’ consensus estimates.